Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Remestemcel-L”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Large-scale testing (Phase 3)Study completedNCT02652130
What this trial is testing

Safety Follow-up of Treatment With Remestemcel-L in Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute GVHD

Who this might be right for
Grade B Acute Graft Versus Host DiseaseGrade C Acute Graft Versus Host DiseaseGrade D Acute Graft Versus Host Disease
Mesoblast, Inc. 32
Not applicableNo Longer AvailableNCT01510431
What this trial is testing

Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease

Who this might be right for
Crohn's Disease
Mesoblast, Inc.
Large-scale testing (Phase 3)Ended earlyNCT04371393
What this trial is testing

MSCs in COVID-19 ARDS

Who this might be right for
Mesenchymal Stromal CellsRemestemcel-LAcute Respiratory Distress Syndrome+1 more
Icahn School of Medicine at Mount Sinai 223
Testing effectiveness (Phase 2)Ended earlyNCT04543994
What this trial is testing

Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Ulcerative Colitis (UC)

Who this might be right for
Ulcerative Colitis
The Cleveland Clinic 7
Not applicableNo Longer AvailableNCT04456439
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

Who this might be right for
Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
Mesoblast International Sàrl
Not applicableNo Longer AvailableNCT04366830
What this trial is testing

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Acute Respiratory Distress Syndrome (ARDS) Due to COVID-19 Infection

Who this might be right for
Moderate to Severe Acute Respiratory Distress Syndrome Associated With COVID-19
Mesoblast International Sàrl
Large-scale testing (Phase 3)Study completedNCT02336230
What this trial is testing

A Prospective Study of Remestemcel-L, Ex-vivo Cultured Adult Human Mesenchymal Stromal Cells, for the Treatment of Pediatric Participants Who Have Failed to Respond to Steroid Treatment for Acute Graft-Versus-Host Disease (aGVHD)

Who this might be right for
Grade B aGVHDGrade C aGVHDGrade D aGVHD
Mesoblast, Inc. 55
Large-scale testing (Phase 3)Study completedNCT01233960
What this trial is testing

Evaluation of PROCHYMAL® for Treatment-refractory Moderate-to-severe Crohn's Disease

Who this might be right for
Crohn's Disease
Mesoblast, Inc. 73
Testing effectiveness (Phase 2)Ended earlyNCT04548583
What this trial is testing

Study of Mesenchymal Stem Cells for the Treatment of Medically Refractory Crohn's Colitis

Who this might be right for
Crohn Colitis
The Cleveland Clinic 7